Dabigatran-13C6 |
|
Synonyms: N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-13C6-5-yl]carbonyl]-N-2-pyridinyl-ß-alanine; BIBR 953-13C6; BIBR 953ZW-13C6; | |
Cat. No.: D00188 | CAS No.: Unlablled : 211914-51-1 |
MDL.: | Formula: C1913CH15N7O4 |
F.W.477.48 | Purity: 99% |
Storage: | |
  |
Catalog Number: | D00188 | CAS No.: | Unlablled : 211914-51-1 | |
MDL: | Formula: | C1913CH15N7O4 | ||
F.W.: | 477.48 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Stability: | |||
Storage: | Category: | Reference Standard | ||
Reference: | Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005), | |||
Application: | Dabigatran-d7, is the labeled analogue of Dabigatran, Nonpeptide, direct thrombin inhibitor. Antithrombotic. | |||
Category: | Aromatics, Heterocycles, Isotope Labelled Compounds, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |